| Variable |
Hazard ratio* (95% CI) |
p |
| Age |
|
|
|
| ≤30 |
14 |
1.6(1.30-2.10) |
0.000 |
| 30-40 |
8.6 |
1.30(1.10-1.60) |
0.012 |
| >40 |
5 |
1 |
|
| Gender |
|
|
|
| Female |
7 |
1 |
|
| Male |
8 |
1.10(0.90-130) |
0.5 |
| HIV diagnosis period |
|
|
|
| 2005-2008 |
2.5 |
1 |
|
| 1997-2004 |
7 |
3.10(2.26-4.23) |
0.000 |
| 1988-1996 |
14 |
4.8(3.50-6.50) |
0.000 |
| CD4 cell count |
|
|
|
| Initial CD4<200/mm3 |
3 |
0.47(0.34-0.65) |
0.000 |
| Initial CD4<200-499/mm3 |
7.3 |
0.82(0.68-0.98) |
0.032 |
| Initial CD4>500/mm3 |
11 |
1 |
|
| CDC categories |
|
|
|
| A |
11 |
1 |
|
| B |
6 |
0.70 (0.53-0.85) |
0.001 |
| C |
2.7 |
0.38(0.28-0.53) |
0.000 |
| Known drug
use/addiction |
|
|
|
| no |
8 |
1 |
|
| yes |
10 |
0.7(0.31-1.50) |
0.4 |
| ARV therapy |
|
|
|
| HAART+ |
4 |
0.63(0.51-0.80) |
0.000 |
| HAART- |
12 |
1 |
|
*Obtained using a Cox proportional hazard model including all the above mentioned
covariates.
CI: confidence interval; py: person-years |
